Bipolar disorder, current episode mixed, severe, with psychotic features
Methodology & AI Transparency ⓘ
Bipolar disorder, current episode mixed, severe, with psychotic features Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Within Depression, Bipolar & Mood Disorders practice, Bipolar disorder, current episode mixed, severe, with psychotic features (ICD-10 F31.64) is stratified through medical mimic exclusion in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: (thyroid), pairing targeted symptom control with longitudinal TSH & Free in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: T4 Rule-Out) surveillance.
- 2 Real-world patient consensus: Mapped to Depression, Bipolar & Mood Disorders under ICD-10-CM F31.64 for Bipolar disorder, current episode mixed, severe, with psychotic features clinical workups.
- 3 Typical cash cost range: Primary evaluation for Bipolar disorder, current episode mixed, severe, with psychotic features incorporates medical mimic exclusion in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: (thyroid) and symptom diary review.
- 4 Top reported side effects / signs: Longitudinal Bipolar disorder, current episode mixed, severe, with psychotic features monitoring tracks PHQ-9 Symptom Severity in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: Score) toward < 4 (clinical remission) (F31.64).
Ask our AI Specialists anything about Bipolar disorder, current episode mixed, severe, with psychotic features
What Is Bipolar disorder, current episode mixed, severe, with psychotic features?
Within Depression, Bipolar & Mood Disorders practice, Bipolar disorder, current episode mixed, severe, with psychotic features (ICD-10 F31.64) is stratified through medical mimic exclusion in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: (thyroid), pairing targeted symptom control with longitudinal TSH & Free in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: T4 Rule-Out) surveillance.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64) center on monoaminergic (serotonin [Bipolar disorder, current episode mixed, severe, with psychotic features F31.64]. targeted depression & mood interventions aim to normalize PHQ-9 Symptom Severity in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: Score).
Common Symptoms & Clinical Signs
- • Presentation of Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64): disrupted sleep architecture [Bipolar disorder, current episode mixed, severe, with psychotic features F31.64]
- • Secondary Bipolar disorder, current episode mixed, severe, with psychotic features clinical sign: slowed concentration, indecisiveness, in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: and physical heaviness)
- • Symptom flares in Bipolar disorder, current episode mixed, severe, with psychotic features correlating with PHQ-9 Symptom Severity in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: Score) deviation outside < 4 (clinical remission) (F31.64)
- • Functional depression & mood impact requiring medical mimic exclusion in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: (thyroid) evaluation (F31.64)
Bipolar disorder, current episode mixed, severe, with psychotic features Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F31.64 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Depression, Bipolar & Mood Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: PHQ-9 Symptom Severity in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: Score) | < 4 (clinical remission) (F31.64) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: TSH & Free in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: T4 Rule-Out) | TSH 0.8 – 2.5 mIU/L (F31.64) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin D in Bipolar disorder, current episode mixed, severe, with psychotic features (F31.64: & RBC Folate) | 25(OH)D 40 – 65 ng/mL (F31.64) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Bipolar disorder, current episode mixed, severe, with psychotic features
Treatment selection for Bipolar disorder, current episode mixed, severe, with psychotic features depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Bipolar disorder, current episode mixed, severe, with psychotic features)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Efficacy of Lumateperone in Patients With Bipolar Depression With Mixed: What a 376-Participant Study Found Conclusions: Lumateperone 42 mg significantly improved symptoms of depression and disease severity in patients with an MDE associated with bipolar I or bipolar II disorder, with or without mixed features. The Journal of clinical psychiatry • 2023-04-24 • Phase III Randomized Trial | N = 376 | 93/100 | PMID 37103915 ↗ |
| Can This Approach Help? Inside the Latest Research on Exercise fails to improve neurocognition in depressed middle-aged and older We found little evidence to support the benefits of an aerobic exercise intervention on neurocognitive performance in patients with MDD. Medicine and science in sports and exercise • 2008-07-15 • Randomized Controlled Trial | N = 49 | 88/100 | PMID 18580416 ↗ |
| Can This Approach Help? Inside the Latest Research on Duration of Adjunctive Antidepressant Maintenance in Bipolar I In a trial involving patients with bipolar I disorder and a recently remitted depressive episode, adjunctive treatment with escitalopram or bupropion XL that continued for 52 weeks did not show a significant benefit as... The New England journal of medicine • 2023-08-03 • Randomized Controlled Trial | N = 90 | 88/100 | PMID 37530824 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of Lumateperone for Major Depressive Episodes Associated With Lumateperone at 42 mg/day significantly improved depression symptoms and was generally well tolerated in patients with major depressive episodes associated with both bipolar I and bipolar II disorders. The American journal of psychiatry • 2021-12-15 • Phase III Randomized Trial | N = 188 | 88/100 | PMID 34551584 ↗ |
| Can This Approach Help? Inside the Latest Research on Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results Lumateperone 42-mg treatment adjunctive to lithium or valproate significantly improved depression symptoms and was generally well tolerated in patients with MDEs associated with either bipolar I or bipolar II disorder. Bipolar disorders • 2023-09-15 • Phase III Randomized Trial | N = 176 | 88/100 | PMID 36779257 ↗ |
Bipolar disorder, current episode mixed, severe, with psychotic features Patient Community & “People Like Me” Threads
Filter Bipolar disorder, current episode mixed, severe, with psychotic features community threads and patient logs by age, biological sex, dosage, and treatment duration.